Sign in
4

Changes in Ownership

Altimmune, Inc. Filed Acc 0001104659-22-076291

Chief Scientific Officer sold 5,462 shares at $12.00 ($65,546)

  • Chief Scientific Officer acquired 5,462 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Roberts M Scot · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-06-29 Exercise or conversion : show line 1 in the form +5,462 $2.60 $14,201 23,162 D
2022-06-29 Sale : show line 2 in the form −5,462 $12.00 $65,546 17,700 D
Open-market sales · 5,462 sh · avg $12.00 · $65,546

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-06-29 Exercise or conversion : show line 3 in the form Stock Options (option to buy) −5,462 12,769 D
Loading xslF345X03/tm2220183-1_4seq1.xml…